Cargando…
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
[Image: see text] Severe cases of coronavirus disease 2019 (COVID-19), caused by infection with SARS-CoV-2, are characterized by a hyperinflammatory immune response that leads to numerous complications. Production of proinflammatory neutrophil extracellular traps (NETs) has been suggested to be a ke...
Autores principales: | Delaveris, Corleone S., Wilk, Aaron J., Riley, Nicholas M., Stark, Jessica C., Yang, Samuel S., Rogers, Angela J., Ranganath, Thanmayi, Nadeau, Kari C., Blish, Catherine A., Bertozzi, Carolyn R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009098/ https://www.ncbi.nlm.nih.gov/pubmed/34056095 http://dx.doi.org/10.1021/acscentsci.0c01669 |
Ejemplares similares
-
Synthetic Siglec-9 agonists inhibit neutrophil activation associated with COVID-19
por: Delaveris, Corleone S., et al.
Publicado: (2020) -
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
por: Smith, Benjamin A. H., et al.
Publicado: (2023) -
Microglia mediate contact-independent neuronal pruning via secreted Neuraminidase-3 associated with extracellular vesicles
por: Delaveris, Corleone S., et al.
Publicado: (2023) -
Microglia Mediate
Contact-Independent Neuronal Network
Remodeling via Secreted Neuraminidase-3 Associated with Extracellular
Vesicles
por: Delaveris, Corleone S., et al.
Publicado: (2023) -
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
por: Smith, Benjamin A. H., et al.
Publicado: (2021)